Latest News

CF Industries Holdings (CF) has been grinding lower recently, with the stock down around 12 % over the past 3 months and about 13 % over the past year, despite still solid long term returns. See our latest analysis for CF Industries Holdings. That recent slide, including an 8.2 % 30 day share price return and double digit year to date weakness, signals fading momentum in the near term. Even though the five year total shareholder return above 100 % still underscores substantial long run wealth...

Webster Financial Corporation, the parent of Webster Bank, recently lowered its prime lending rate to 6.75% from 7.00%, effective December 11, 2025, affecting borrowing costs for its consumer and commercial customers across its Northeast footprint. This adjustment in Webster’s prime rate offers insight into how management is aligning lending terms with broader interest-rate conditions and client demand, which could influence the mix and growth of its loan portfolio. Next, we’ll examine how...

Barclays has just upgraded Pernod Ricard (ENXTPA:RI) to overweight, arguing the spirits group looks mispriced given reduced China exposure, improving India dynamics, and a long runway in the U.S. and Indian markets. See our latest analysis for Pernod Ricard. The upgrade lands after a tough stretch, with a roughly 30 percent year to date share price decline and a three year total shareholder return of about negative 54 percent, but today’s bounce hints that sentiment may be starting to...

In recent months, TPG Telecom has faced intense regulatory scrutiny and a Senate inquiry in Australia after multiple Triple Zero (000) emergency call failures involving outdated Samsung devices on its network, with the company working with authorities to investigate possible links to customer deaths and urging tens of thousands of affected users to update their software or replace handsets. At the same time, TPG completed a retail reinvestment plan that raised A$73.40 million to repay bank...

Granite Real Estate Investment Trust (TSX:GRT.UN) is shaking up its U.S. presence by voluntarily delisting from the New York Stock Exchange and deregistering from SEC reporting in order to cut costs and streamline its structure. See our latest analysis for Granite Real Estate Investment Trust. That efficiency push comes after a steady run, with Granite’s units recently closing at CA$76.86 and a solid year to date share price return of around 10 percent alongside a similar 1 year total...

In recent days, UBS resumed coverage of Hamilton Lane with a Buy rating and Goldman Sachs upgraded the firm to Buy after its fiscal 2026 second-quarter earnings surpassed analyst expectations, underscoring confidence in its evergreen wealth strategy and exposure to private markets and secondary transactions. This wave of positive analyst attention highlights how Hamilton Lane’s expanding presence in retail-focused alternatives and diversified private market access is becoming a central part...

First Capital Real Estate Investment Trust (TSX:FCR.UN) has quietly outperformed over the past year, and that steady climb has investors asking whether the current pullback is a healthy pause or a buying opportunity. See our latest analysis for First Capital Real Estate Investment Trust. Recent trading has been a bit choppy, with the share price easing back to about $18.70. Even so, the year to date share price return remains positive and the 1 year total shareholder return still points to...

Toll Brothers recently reported mixed fourth-quarter 2025 results, with revenue rising to US$3,423.4 million while net income slipped to US$446.72 million and earnings per share came in below analyst expectations amid a softer demand backdrop and a 15% decline in backlog. At the same time, the builder is pressing ahead with new luxury communities such as Wilder Ranch in Colorado, Rivercrest in Nevada, and expanded offerings in Washington, underscoring its focus on affluent buyers even as it...

Roche’s upbeat Phase 3 data for its breast cancer SERD giredestrant has lit a fire under Olema Pharmaceuticals (OLMA), with investors recalibrating expectations around the company’s own SERD candidate, palazestrant. See our latest analysis for Olema Pharmaceuticals. The latest pop, including a 15.43% 1 day share price return and a 252.64% 30 day share price return, builds on a powerful backdrop of a 450.81% year to date share price return and a 1152.24% three year total shareholder return...

Advanced Drainage Systems (WMS) is back on investors radar after a recent fund commentary highlighted its better than expected sales and earnings, as well as a reaffirmed fiscal 2026 outlook despite choppy construction markets. See our latest analysis for Advanced Drainage Systems. The latest fund commentary seems to have reminded the market what is working under the hood, with the share price now at $149.6 and a strong year to date share price return of 30.85 percent feeding into a solid 5...

Wondering whether Civitas Resources is a value play or a value trap at today’s price? You are not alone. This stock has quietly shifted from market favorite to contrarian idea. The share price has bounced about 10.5% over the last month but is still down roughly 36.4% year to date and 33.8% over the last year, a mix that often signals either a looming problem or a mispriced opportunity. Recent headlines around Civitas have focused on its portfolio positioning and capital discipline in a...

Key Insights Autosports Group's estimated fair value is AU$6.19 based on 2 Stage Free Cash Flow to Equity Autosports...

The Cogstate Limited ( ASX:CGS ) share price has softened a substantial 27% over the previous 30 days, handing back...

From what we can see, insiders were net sellers in BlueScope Steel Limited's ( ASX:BSL ) during the past 12 months...

TerraVest Industries (TSX:TVK) just posted fourth quarter and full year results that turned heads, with revenue and net income climbing sharply year over year, giving investors fresh numbers to rethink the stock’s trajectory. See our latest analysis for TerraVest Industries. The earnings beat slots neatly into a strong year for TerraVest, with a 14.75% year to date share price return and a powerful 3 year total shareholder return of 413.30%, suggesting momentum is consolidating after a recent...

In recent days, analysts have warned that rising AI-driven memory costs and intensifying competition from Nvidia and AMD could pressure Intel’s core PC and server businesses, particularly its margins. These concerns come alongside governance questions around CEO Lip-Bu Tan’s venture ties, ongoing legal disputes, and mixed progress on Intel’s efforts to reposition itself as an AI and foundry player. What stands out is that Intel is being labeled an “AI loser” by some analysts at the same time...

Travelers Companies (TRV) has been drifting slightly lower over the past week, even after a strong year-to-date run. This naturally raises the question of whether this dip offers a reasonable entry point. See our latest analysis for Travelers Companies. The latest pullback leaves Travelers shares at $278.35, still comfortably ahead for the year thanks to a solid year to date share price return and strong multi year total shareholder returns. This suggests that momentum is cooling rather than...

Byrna Technologies Inc. recently issued preliminary guidance for its fiscal fourth quarter and full year ended November 30, 2025, expecting revenue of US$35.1 million for the quarter and US$118.0 million for the year, both reflecting solid year-over-year growth across dealer, retail, direct-to-consumer, and international channels. The company attributes this performance to broader brand visibility, a wider physical retail footprint, and the successful launch of its Byrna CL launcher,...

If you are wondering whether Ultragenyx Pharmaceutical at around $36 a share is a hidden bargain or another biotech value trap, you are in the right place to unpack what the market is really pricing in. The stock is up about 8.3% over the last month but still down sharply over 1 year and 5 years. This pattern suggests sentiment may be shifting even while longer term holders are still deep in the red. Recent attention on Ultragenyx has centered on its rare disease pipeline progress and...

Investor (OM:INVE A) has appointed Ulrika Elfving as its new General Counsel and Executive Leadership Team member, a governance focused move that could subtly shape risk management and long term value creation. See our latest analysis for Investor. The market seems to be taking this leadership change in its stride. The latest share price is SEK 318.8, and a solid 90 day share price return of 11.55 percent is backing up a strong multi year total shareholder return profile. This suggests that...

Critical Metals (CRML) just took a big strategic step, executing a 50/50 joint venture term sheet with Romanian state-owned FPCU to build a rare earth processing facility in the European Union without adding debt or equity dilution. See our latest analysis for Critical Metals. The JV news lands after a volatile run, with the 90 day share price return of 44.9 percent and year to date share price return of 37.9 percent contrasting with a softer 22.2 percent one year total shareholder return...

Recent performance sets the stage PTC (PTC) has quietly slipped over the past 3 months, even though its revenue and net income keep growing at mid single digit rates. That gap between fundamentals and share performance is what matters now for investors. See our latest analysis for PTC. The 1 year total shareholder return of negative 12.7 percent, despite a 3 year total shareholder return above 40 percent, suggests momentum has cooled as investors reassess how much they are willing to pay for...

Klarna Group (KLAR) has been on a bumpy ride lately, with the stock sliding over the past 3 months even as revenue and net income growth point to an improving underlying business trajectory. See our latest analysis for Klarna Group. Despite the steady operational progress, Klarna Group’s share price return has been choppy, with a 1 day share price return of 4.76 percent and 7 day share price return of 5.07 percent, which partly offset a weaker 90 day share price return of negative 24.78...

Cullen/Frost Bankers (CFR) has quietly outperformed over the past month, with shares up about 5%, even as its year to date return remains slightly negative. That mix sets up an interesting value check. See our latest analysis for Cullen/Frost Bankers. That recent 4.6% one-month share price return, alongside a modest 5-year total shareholder return of about 70%, suggests long-term holders have still been rewarded even as near-term momentum is only just starting to pick back up around 129.95...